286 is the total number of securities Parkman Healthcare Partners LLC has owned. The longest Parkman Healthcare Partners LLC has owned a single stock is 16 quarters.
| Period | Weighting | Quarter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| DXCM | DEXCOM INC | 16 | 16 | 0.92% | 3.08% | 6.29% | Q4 2019 | Q3 2023 | 16 |
| ACRS | ACLARIS THERAPEUTICS INC | 16 | 16 | 0.12% | 2.43% | 10.00% | Q4 2019 | Q3 2023 | 16 |
| XENE | XENON PHARMACEUTICALS INC | 16 | 16 | 1.20% | 2.05% | 3.30% | Q4 2019 | Q3 2023 | 16 |
| NTRA | NATERA INC | 16 | 16 | 0.41% | 1.85% | 3.35% | Q4 2019 | Q3 2023 | 16 |
| CDMO | AVID BIOSERVICES INC | 14 | 1 | 0.23% | 1.66% | 2.86% | Q4 2019 | Q3 2023 | 15 |
| SDGR | SCHRODINGER INC | 15 | 15 | 0.39% | 1.38% | 4.18% | Q1 2020 | Q3 2023 | 15 |
| KRMD | REPRO MED SYS INC | 15 | 15 | 0.16% | 0.78% | 1.99% | Q4 2019 | Q2 2023 | 15 |
| MNKD | MANNKIND CORP | 11 | 4 | 0.18% | 0.77% | 1.57% | Q4 2019 | Q3 2023 | 15 |
| IQV | IQVIA HLDGS INC | 14 | 14 | 0.84% | 2.62% | 4.55% | Q4 2019 | Q1 2023 | 14 |
| PODD | INSULET CORP | 14 | 14 | 0.96% | 1.66% | 2.90% | Q2 2020 | Q3 2023 | 14 |
| RCUS | ARCUS BIOSCIENCES INC | 14 | 14 | 0.41% | 1.18% | 2.09% | Q2 2020 | Q3 2023 | 14 |
| IMUX | IMMUNIC INC | 14 | 14 | 0.15% | 1.17% | 3.60% | Q2 2020 | Q3 2023 | 14 |
| DHR | DANAHER CORPORATION | 13 | 13 | 0.83% | 3.08% | 4.27% | Q2 2020 | Q2 2023 | 13 |
| STRO | SUTRO BIOPHARMA INC | 13 | 13 | 0.35% | 0.91% | 1.86% | Q3 2020 | Q3 2023 | 13 |
| MDGL | MADRIGAL PHARMACEUTICA... | 13 | 13 | 0.37% | 0.77% | 1.60% | Q1 2020 | Q1 2023 | 13 |
| ALNY | ALNYLAM PHARMACEUTICAL... | 12 | 12 | 0.62% | 1.82% | 3.58% | Q4 2019 | Q3 2022 | 12 |
| CTLT | CATALENT INC | 10 | 2 | 0.67% | 1.70% | 2.67% | Q2 2020 | Q3 2023 | 12 |
| ATEC | ALPHATEC HOLDINGS INC | 6 | 6 | 0.37% | 0.95% | 1.87% | Q4 2019 | Q4 2022 | 12 |
| AXGN | AXOGEN INC | 12 | 12 | 0.30% | 0.64% | 1.12% | Q3 2020 | Q2 2023 | 12 |
| UTHR | UNITED THERAPEUTICS CO... | 11 | 11 | 2.91% | 5.02% | 7.97% | Q1 2021 | Q3 2023 | 11 |
| NBIX | NEUROCRINE BIOSCIENCES... | 7 | 4 | 1.73% | 3.49% | 5.16% | Q4 2019 | Q3 2023 | 11 |
| COO | COOPER COS INC | 11 | 11 | 0.67% | 2.09% | 4.25% | Q1 2021 | Q3 2023 | 11 |
| IONS | IONIS PHARMACEUTICALS INC | 6 | 5 | 0.54% | 1.41% | 3.04% | Q4 2020 | Q3 2023 | 11 |
| PFMT | PERFORMANT FINL CORP | 11 | 11 | 0.37% | 0.75% | 1.27% | Q1 2021 | Q3 2023 | 11 |
| ETNB | 89BIO INC | 6 | 5 | 0.37% | 0.74% | 1.15% | Q3 2020 | Q3 2023 | 11 |
| BCYC | BICYCLE THERAPEUTICS PLC | 11 | 11 | 0.37% | 0.63% | 0.87% | Q1 2021 | Q3 2023 | 11 |
| TELA | TELA BIO INC | 10 | 1 | 0.09% | 0.29% | 0.37% | Q4 2019 | Q3 2023 | 11 |
| UNH | UNITEDHEALTH GROUP INC | 5 | 5 | 1.73% | 3.37% | 5.45% | Q4 2019 | Q4 2022 | 10 |
| HUM | HUMANA INC | 6 | 4 | 0.86% | 2.41% | 3.28% | Q2 2020 | Q3 2023 | 10 |
| HAE | HAEMONETICS CORP MASS | 6 | 1 | 0.45% | 1.54% | 2.77% | Q4 2019 | Q3 2023 | 10 |
| SILK | SILK ROAD MEDICAL INC | 6 | 4 | 0.24% | 1.49% | 2.27% | Q4 2019 | Q3 2023 | 10 |
| ANIP | ANI PHARMACEUTICALS INC | 10 | 10 | 0.42% | 1.07% | 1.63% | Q2 2021 | Q3 2023 | 10 |
| BCRX | BIOCRYST PHARMACEUTICA... | 10 | 10 | 0.37% | 1.07% | 2.27% | Q4 2019 | Q1 2022 | 10 |
| SUPN | SUPERNUS PHARMACEUTICA... | 10 | 10 | 0.67% | 0.85% | 1.04% | Q2 2021 | Q3 2023 | 10 |
| MTEM | MOLECULAR TEMPLATES INC | 10 | 10 | 0.10% | 0.72% | 2.11% | Q4 2019 | Q1 2022 | 10 |
| KNSA | KINIKSA PHARMACEUTICAL... | 8 | 2 | 0.30% | 0.59% | 1.62% | Q4 2020 | Q3 2023 | 10 |
| HZNP | HORIZON THERAPEUTICS P... | 9 | 9 | 1.46% | 2.89% | 4.87% | Q4 2019 | Q4 2021 | 9 |
| SGEN | SEAGEN INC | 9 | 9 | 0.75% | 2.85% | 4.99% | Q2 2021 | Q2 2023 | 9 |
| CRL | CHARLES RIV LABS INTL INC | 8 | 1 | 0.83% | 2.41% | 4.22% | Q2 2020 | Q3 2023 | 9 |
| ICAD | ICAD INC | 9 | 9 | 0.16% | 1.64% | 3.19% | Q4 2019 | Q4 2021 | 9 |
| KOD | KODIAK SCIENCES INC | 9 | 9 | 0.66% | 1.40% | 3.62% | Q4 2019 | Q4 2021 | 9 |
| STXS | STEREOTAXIS INC | 9 | 9 | 0.56% | 0.85% | 1.43% | Q4 2019 | Q4 2021 | 9 |
| VCYT | VERACYTE INC | 9 | 9 | 0.29% | 0.62% | 0.94% | Q3 2021 | Q3 2023 | 9 |
| SURF | SURFACE ONCOLOGY INC | 9 | 9 | 0.07% | 0.32% | 0.48% | Q2 2020 | Q2 2022 | 9 |
| TKNO | ALPHA TEKNOVA INC | 9 | 9 | 0.08% | 0.27% | 0.51% | Q3 2021 | Q3 2023 | 9 |
| THC | TENET HEALTHCARE CORP | 8 | 8 | 0.72% | 2.34% | 3.58% | Q4 2021 | Q3 2023 | 8 |
| DRNA | DICERNA PHARMACEUTICAL... | 8 | 8 | 1.07% | 1.88% | 2.56% | Q4 2019 | Q3 2021 | 8 |
| VCEL | VERICEL CORP | 8 | 8 | 0.23% | 1.62% | 3.17% | Q4 2019 | Q3 2021 | 8 |
| KROS | KEROS THERAPEUTICS INC | 8 | 8 | 0.49% | 1.32% | 1.93% | Q4 2021 | Q3 2023 | 8 |
| BBIO | BRIDGEBIO PHARMA INC | 7 | 1 | 0.48% | 0.84% | 1.39% | Q1 2020 | Q3 2023 | 8 |
| FULC | FULCRUM THERAPEUTICS INC | 8 | 8 | 0.34% | 0.83% | 2.42% | Q1 2021 | Q4 2022 | 8 |
| AKYA | AKOYA BIOSCIENCES INC | 8 | 8 | 0.36% | 0.51% | 0.87% | Q4 2021 | Q3 2023 | 8 |
| BLRX | BIOLINERX LTD | 8 | 8 | 0.08% | 0.23% | 0.45% | Q4 2020 | Q3 2022 | 8 |
| AVTR | AVANTOR INC | 7 | 7 | 1.09% | 2.49% | 4.55% | Q4 2020 | Q2 2022 | 7 |
| LNTH | LANTHEUS HLDGS INC | 7 | 7 | 0.41% | 1.50% | 3.57% | Q1 2022 | Q3 2023 | 7 |
| ITMR | ITAMAR MED LTD | 7 | 7 | 0.17% | 1.38% | 1.87% | Q4 2019 | Q2 2021 | 7 |
| APEN | APOLLO ENDOSURGERY INC | 7 | 7 | 0.10% | 1.18% | 1.90% | Q1 2021 | Q3 2022 | 7 |
| CDXS | CODEXIS INC | 7 | 7 | 0.18% | 1.17% | 2.35% | Q1 2021 | Q3 2022 | 7 |
| IDXX | IDEXX LABS INC | 7 | 7 | 0.78% | 1.14% | 1.59% | Q3 2020 | Q1 2022 | 7 |
| SPNE | SEASPINE HLDGS CORP | 7 | 7 | 0.39% | 0.99% | 1.68% | Q4 2019 | Q2 2021 | 7 |
| INFU | INFUSYSTEM HLDGS INC | 7 | 7 | 0.31% | 0.87% | 1.32% | Q4 2019 | Q2 2021 | 7 |
| IMVT | IMMUNOVANT INC | 4 | 3 | 0.29% | 0.76% | 1.40% | Q1 2020 | Q2 2023 | 7 |
| OM | OUTSET MED INC | 7 | 7 | 0.09% | 0.61% | 1.08% | Q3 2020 | Q1 2022 | 7 |
| HCAT | HEALTH CATALYST INC | 7 | 7 | 0.34% | 0.60% | 0.84% | Q4 2020 | Q2 2022 | 7 |
| AUPH | AURINIA PHARMACEUTICAL... | 7 | 7 | 0.14% | 0.44% | 0.81% | Q4 2019 | Q2 2021 | 7 |
| CBIO | CATALYST BIOSCIENCES INC | 7 | 7 | 0.14% | 0.33% | 0.46% | Q1 2020 | Q3 2021 | 7 |
| MIRM | MIRUM PHARMACEUTICALS INC | 7 | 7 | 0.20% | 0.28% | 0.38% | Q1 2022 | Q3 2023 | 7 |
| BSX | BOSTON SCIENTIFIC CORP | 5 | 1 | 3.59% | 4.47% | 5.78% | Q4 2019 | Q3 2023 | 6 |
| ABBV | ABBVIE INC | 3 | 3 | 0.82% | 1.73% | 2.17% | Q2 2020 | Q1 2022 | 6 |
| TPTX | TURNING POINT THERAPEU... | 6 | 6 | 0.31% | 1.70% | 2.55% | Q4 2019 | Q1 2021 | 6 |
| XLRN | ACCELERON PHARMA INC | 6 | 6 | 1.49% | 1.66% | 1.98% | Q1 2020 | Q2 2021 | 6 |
| EW | EDWARDS LIFESCIENCES CORP | 3 | 1 | 0.51% | 1.60% | 2.59% | Q2 2020 | Q3 2023 | 6 |
| GOSS | GOSSAMER BIO INC | 6 | 6 | 0.51% | 1.32% | 2.50% | Q4 2020 | Q1 2022 | 6 |
| RXSIGHT INC | 6 | 6 | 0.57% | 1.29% | 2.49% | Q2 2022 | Q3 2023 | 6 | |
| DAWN | DAY ONE BIOPHARMACEUTI... | 6 | 6 | 0.76% | 1.06% | 1.29% | Q2 2022 | Q3 2023 | 6 |
| ARCELLX INC | 6 | 6 | 0.75% | 1.05% | 1.34% | Q2 2022 | Q3 2023 | 6 | |
| MRVI | MARAVAI LIFESCIENCES H... | 6 | 6 | 0.79% | 0.90% | 1.12% | Q4 2020 | Q1 2022 | 6 |
| ALT | ALTIMMUNE INC | 5 | 1 | 0.29% | 0.79% | 2.41% | Q4 2020 | Q2 2022 | 6 |
| TRILLIUM THERAPEUTICS INC | 6 | 6 | 0.38% | 0.72% | 1.41% | Q1 2020 | Q2 2021 | 6 | |
| HBIO | HARVARD BIOSCIENCE INC | 6 | 6 | 0.22% | 0.71% | 1.15% | Q2 2021 | Q3 2022 | 6 |
| COGT | COGENT BIOSCIENCES INC | 6 | 6 | 0.35% | 0.59% | 1.00% | Q2 2022 | Q3 2023 | 6 |
| TVTX | TRAVERE THERAPEUTICS INC | 6 | 6 | 0.13% | 0.43% | 0.95% | Q2 2022 | Q3 2023 | 6 |
| SIEN | SIENTRA INC | 6 | 6 | 0.07% | 0.35% | 0.64% | Q2 2021 | Q3 2022 | 6 |
| SLN | SILENCE THERAPEUTICS PLC | 6 | 6 | 0.12% | 0.29% | 0.55% | Q2 2022 | Q3 2023 | 6 |
| LXRX | LEXICON PHARMACEUTICAL... | 6 | 6 | 0.17% | 0.28% | 0.53% | Q2 2022 | Q3 2023 | 6 |
| OPNT | OPIANT PHARMACEUTICALS... | 6 | 6 | 0.20% | 0.25% | 0.33% | Q3 2021 | Q4 2022 | 6 |
| GWPH | GW PHARMACEUTICALS PLC | 5 | 5 | 1.29% | 3.14% | 4.98% | Q4 2019 | Q4 2020 | 5 |
| IRTC | IRHYTHM TECHNOLOGIES INC | 5 | 5 | 0.48% | 2.15% | 4.79% | Q3 2021 | Q3 2022 | 5 |
| WAT | WATERS CORP | 5 | 5 | 0.80% | 1.76% | 3.20% | Q2 2022 | Q2 2023 | 5 |
| VRNA | VERONA PHARMA PLC | 5 | 5 | 0.94% | 1.73% | 2.88% | Q3 2022 | Q3 2023 | 5 |
| CTIC | CTI BIOPHARMA CORP | 5 | 5 | 0.31% | 1.70% | 2.31% | Q1 2022 | Q1 2023 | 5 |
| GNMK | GENMARK DIAGNOSTICS INC | 5 | 5 | 0.38% | 1.68% | 3.32% | Q4 2019 | Q4 2020 | 5 |
| DCPH | DECIPHERA PHARMACEUTIC... | 5 | 5 | 1.39% | 1.51% | 1.65% | Q3 2022 | Q3 2023 | 5 |
| EIDX | EIDOS THERAPEUTICS INC | 5 | 5 | 0.55% | 1.42% | 3.43% | Q4 2019 | Q4 2020 | 5 |
| LEGN | LEGEND BIOTECH CORP | 5 | 5 | 0.50% | 1.36% | 2.39% | Q1 2022 | Q1 2023 | 5 |
| KRTX | KARUNA THERAPEUTICS INC | 5 | 5 | 0.77% | 1.35% | 1.85% | Q3 2022 | Q3 2023 | 5 |
| RCM | R1 RCM INC | 3 | 2 | 0.36% | 1.26% | 2.69% | Q4 2019 | Q1 2022 | 5 |
| CNCE | CONCERT PHARMACEUTICAL... | 4 | 1 | 0.16% | 1.26% | 2.17% | Q4 2020 | Q4 2022 | 5 |
| NUAN | NUANCE COMMUNICATIONS INC | 5 | 5 | 0.89% | 1.14% | 1.41% | Q1 2020 | Q1 2021 | 5 |
| AVRO | AVROBIO INC | 5 | 5 | 0.43% | 0.92% | 2.13% | Q4 2019 | Q4 2020 | 5 |
| KDMN | KADMON HLDGS INC | 5 | 5 | 0.42% | 0.82% | 1.05% | Q2 2020 | Q2 2021 | 5 |
| ESPR | ESPERION THERAPEUTICS ... | 5 | 5 | 0.36% | 0.69% | 1.36% | Q3 2022 | Q3 2023 | 5 |
| KALA | KALA PHARMACEUTICALS INC | 5 | 5 | 0.23% | 0.61% | 0.92% | Q1 2020 | Q1 2021 | 5 |
| XFOR | X4 PHARMACEUTICALS INC | 5 | 5 | 0.16% | 0.61% | 1.27% | Q3 2022 | Q3 2023 | 5 |
| ONCT | ONCTERNAL THERAPEUTICS... | 5 | 5 | 0.14% | 0.58% | 1.50% | Q4 2020 | Q4 2021 | 5 |
| NEPH | NEPHROS INC | 5 | 5 | 0.37% | 0.55% | 0.73% | Q4 2019 | Q4 2020 | 5 |
| CSTL | CASTLE BIOSCIENCES INC | 3 | 2 | 0.26% | 0.42% | 0.70% | Q2 2020 | Q3 2023 | 5 |
| ZYME | ZYMEWORKS INC | 4 | 1 | 0.15% | 0.38% | 1.05% | Q3 2020 | Q2 2022 | 5 |
| LQDA | LIQUIDIA CORPORATION | 5 | 5 | 0.14% | 0.37% | 0.49% | Q3 2022 | Q3 2023 | 5 |
| REPH | SOCIETAL CDMO INC | 5 | 5 | 0.24% | 0.36% | 0.40% | Q1 2021 | Q1 2022 | 5 |
| SNDX | SYNDAX PHARMACEUTICALS... | 3 | 2 | 0.12% | 0.35% | 0.76% | Q2 2020 | Q3 2023 | 5 |
| EWTX | EDGEWISE THERAPEUTICS INC | 5 | 5 | 0.09% | 0.29% | 0.61% | Q3 2022 | Q3 2023 | 5 |
| VSTM | VERASTEM INC | 4 | 1 | 0.08% | 0.11% | 0.14% | Q4 2020 | Q1 2022 | 5 |
| MRK | MERCK & CO. INC | 4 | 4 | 2.74% | 4.74% | 7.70% | Q4 2019 | Q3 2020 | 4 |
| VRTX | VERTEX PHARMACEUTICALS... | 4 | 4 | 1.62% | 2.71% | 4.72% | Q4 2019 | Q3 2020 | 4 |
| CVS | CVS HEALTH CORP | 4 | 4 | 1.83% | 2.65% | 3.19% | Q4 2021 | Q3 2022 | 4 |
| ISRG | INTUITIVE SURGICAL INC | 2 | 1 | 0.80% | 2.37% | 3.94% | Q4 2019 | Q3 2022 | 4 |
| ANTM | ELEVANCE HEALTH INC | 4 | 4 | 1.68% | 2.30% | 3.16% | Q2 2022 | Q1 2023 | 4 |
| AXNX | AXONICS MODULATION TEC... | 4 | 4 | 1.33% | 2.24% | 2.85% | Q4 2019 | Q3 2020 | 4 |
| PCVX | VAXCYTE INC | 4 | 4 | 1.52% | 1.93% | 2.22% | Q4 2022 | Q3 2023 | 4 |
| XRAY | DENTSPLY SIRONA INC | 4 | 4 | 0.74% | 1.09% | 1.53% | Q1 2021 | Q4 2021 | 4 |
| PROCEPT BIOROBOTICS CORP | 4 | 4 | 0.42% | 1.00% | 1.24% | Q2 2022 | Q1 2023 | 4 | |
| IMAGO BIOSCIENCES INC | 4 | 4 | 0.58% | 0.72% | 0.81% | Q4 2021 | Q3 2022 | 4 | |
| INSP | INSPIRE MED SYS INC | 2 | 2 | 0.53% | 0.72% | 0.98% | Q4 2019 | Q3 2023 | 4 |
| MSON | MISONIX INC | 4 | 4 | 0.42% | 0.68% | 1.14% | Q4 2019 | Q3 2020 | 4 |
| MGTX | MEIRAGTX HOLDINGS PLC | 4 | 4 | 0.46% | 0.55% | 0.78% | Q4 2019 | Q3 2020 | 4 |
| CGEM | CULLINAN ONCOLOGY INC | 4 | 4 | 0.37% | 0.53% | 0.73% | Q4 2022 | Q3 2023 | 4 |
| EDAP | EDAP TMS S A | 4 | 4 | 0.15% | 0.50% | 1.12% | Q3 2020 | Q2 2021 | 4 |
| ESTA | ESTABLISHMENT LABS HLD... | 3 | 1 | 0.24% | 0.46% | 0.69% | Q3 2022 | Q3 2023 | 4 |
| LNDC | LIFECORE BIOMEDICAL INC | 4 | 4 | 0.35% | 0.42% | 0.51% | Q1 2022 | Q4 2022 | 4 |
| BCEL | ATRECA INC | 4 | 4 | 0.13% | 0.34% | 0.54% | Q3 2020 | Q2 2021 | 4 |
| AMRN | AMARIN CORP PLC | 4 | 4 | 0.13% | 0.34% | 0.84% | Q4 2019 | Q3 2020 | 4 |
| PHAT | PHATHOM PHARMACEUTICAL... | 3 | 1 | 0.22% | 0.27% | 0.34% | Q1 2021 | Q2 2022 | 4 |
| CSLT | CASTLIGHT HEALTH INC | 4 | 4 | 0.18% | 0.25% | 0.39% | Q1 2021 | Q4 2021 | 4 |
| PSTV | PLUS THERAPEUTICS INC | 4 | 4 | 0.05% | 0.24% | 0.45% | Q1 2022 | Q4 2022 | 4 |
| FBRX | FORTE BIOSCIENCES INC | 4 | 4 | 0.16% | 0.23% | 0.29% | Q3 2020 | Q2 2021 | 4 |
| RAPT | RAPT THERAPEUTICS INC | 4 | 4 | 0.13% | 0.23% | 0.33% | Q2 2020 | Q1 2021 | 4 |
| ARPO | AERPIO PHARMACEUTICALS... | 4 | 4 | 0.07% | 0.15% | 0.30% | Q3 2020 | Q2 2021 | 4 |
| AFIB | ACUTUS MED INC | 4 | 4 | 0.02% | 0.09% | 0.12% | Q4 2022 | Q3 2023 | 4 |
| BDX | BECTON DICKINSON & CO | 3 | 3 | 2.14% | 3.54% | 4.64% | Q1 2023 | Q3 2023 | 3 |
| LLY | LILLY ELI & CO | 3 | 3 | 2.07% | 2.89% | 3.36% | Q3 2022 | Q1 2023 | 3 |
| SGEN | SEATTLE GENETICS INC | 3 | 3 | 1.80% | 2.55% | 3.96% | Q4 2019 | Q2 2020 | 3 |
| ZBH | ZIMMER BIOMET HOLDINGS... | 1 | 1 | 1.46% | 2.46% | 4.10% | Q4 2019 | Q3 2023 | 3 |
| KPTI | KARYOPHARM THERAPEUTIC... | 3 | 3 | 0.64% | 1.78% | 2.77% | Q4 2019 | Q2 2020 | 3 |
| AMGN | AMGEN INC | 1 | 1 | 0.98% | 1.55% | 2.60% | Q1 2021 | Q3 2023 | 3 |
| ARWR | ARROWHEAD PHARMACEUTIC... | 3 | 3 | 0.68% | 1.42% | 2.50% | Q3 2020 | Q1 2021 | 3 |
| RGEN | REPLIGEN CORP | 3 | 3 | 0.60% | 1.25% | 1.69% | Q2 2021 | Q4 2021 | 3 |
| MRSN | MERSANA THERAPEUTICS INC | 3 | 3 | 0.69% | 1.06% | 1.65% | Q2 2020 | Q4 2020 | 3 |
| EVH | EVOLENT HEALTH INC | 3 | 3 | 0.52% | 0.82% | 1.32% | Q1 2023 | Q3 2023 | 3 |
| NVAX | NOVAVAX INC | 3 | 3 | 0.50% | 0.81% | 0.99% | Q2 2020 | Q4 2020 | 3 |
| IRMD | IRADIMED CORP | 3 | 3 | 0.62% | 0.79% | 1.13% | Q4 2019 | Q2 2020 | 3 |
| AXSM | AXSOME THERAPEUTICS INC | 3 | 3 | 0.64% | 0.74% | 0.93% | Q2 2020 | Q4 2020 | 3 |
| TGTX | TG THERAPEUTICS INC | 3 | 3 | 0.32% | 0.72% | 0.95% | Q1 2023 | Q3 2023 | 3 |
| AKRO | AKERO THERAPEUTICS INC | 2 | 1 | 0.28% | 0.68% | 1.08% | Q2 2020 | Q3 2023 | 3 |
| SAGE | SAGE THERAPEUTICS INC | 2 | 1 | 0.23% | 0.60% | 1.00% | Q1 2020 | Q2 2023 | 3 |
| NOTV | INOTIV INC | 3 | 3 | 0.35% | 0.58% | 0.72% | Q1 2021 | Q3 2021 | 3 |
| HALO | HALOZYME THERAPEUTICS INC | 2 | 1 | 0.37% | 0.54% | 0.84% | Q4 2019 | Q4 2021 | 3 |
| PIRS | PIERIS PHARMACEUTICALS... | 3 | 3 | 0.40% | 0.53% | 0.65% | Q4 2019 | Q2 2020 | 3 |
| NEWAMSTERDAM PHARMA CO... | 3 | 3 | 0.33% | 0.42% | 0.49% | Q1 2023 | Q3 2023 | 3 | |
| ISEE | IVERIC BIO INC | 3 | 3 | 0.26% | 0.40% | 0.51% | Q3 2022 | Q1 2023 | 3 |
| PROF | PROFOUND MED CORP | 3 | 3 | 0.33% | 0.36% | 0.40% | Q3 2020 | Q1 2021 | 3 |
| APRE | APREA THERAPEUTICS INC | 3 | 3 | 0.13% | 0.35% | 0.48% | Q1 2020 | Q3 2020 | 3 |
| MBIO | MUSTANG BIO INC | 3 | 3 | 0.27% | 0.34% | 0.38% | Q4 2019 | Q2 2020 | 3 |
| FLDM | STANDARD BIOTOOLS INC | 2 | 1 | 0.26% | 0.31% | 0.40% | Q4 2019 | Q3 2023 | 3 |
| FMTX | FORMA THERAPEUTICS HLD... | 3 | 3 | 0.20% | 0.28% | 0.34% | Q4 2021 | Q2 2022 | 3 |
| CATABASIS PHARMACEUTIC... | 3 | 3 | 0.24% | 0.27% | 0.30% | Q1 2020 | Q3 2020 | 3 | |
| QTRX | QUANTERIX CORP | 2 | 1 | 0.19% | 0.26% | 0.38% | Q4 2021 | Q3 2023 | 3 |
| VERA | VERA THERAPEUTICS INC | 3 | 3 | 0.11% | 0.15% | 0.22% | Q2 2021 | Q4 2021 | 3 |
| INZY | INOZYME PHARMA INC | 3 | 3 | 0.14% | 0.15% | 0.16% | Q1 2023 | Q3 2023 | 3 |
| TERN | TERNS PHARMACEUTICALS INC | 3 | 3 | 0.04% | 0.13% | 0.19% | Q1 2023 | Q3 2023 | 3 |
| APYX | APYX MED CORP | 3 | 3 | 0.06% | 0.08% | 0.11% | Q4 2019 | Q2 2020 | 3 |
| ABC | CENCORA INC | 2 | 2 | 2.88% | 3.04% | 3.19% | Q2 2023 | Q3 2023 | 2 |
| HCA | HCA HEALTHCARE INC | 1 | 1 | 2.53% | 2.70% | 2.87% | Q4 2021 | Q3 2023 | 2 |
| IMGN | IMMUNOGEN INC | 2 | 2 | 2.09% | 2.42% | 2.75% | Q2 2023 | Q3 2023 | 2 |
| XBI | SPDR SER TR | 1 | 1 | 2.06% | 2.21% | 2.36% | Q4 2019 | Q2 2020 | 2 |
| TFX | TELEFLEX INCORPORATED | 1 | 1 | 1.30% | 1.66% | 2.02% | Q4 2019 | Q1 2022 | 2 |
| R1 RCM INC | 2 | 2 | 1.47% | 1.62% | 1.78% | Q2 2022 | Q3 2022 | 2 | |
| SWAV | SHOCKWAVE MED INC | 2 | 2 | 0.50% | 1.35% | 2.21% | Q1 2023 | Q2 2023 | 2 |
| RYTM | RHYTHM PHARMACEUTICALS... | 2 | 2 | 1.22% | 1.27% | 1.31% | Q3 2022 | Q4 2022 | 2 |
| TMO | THERMO FISHER SCIENTIF... | 1 | 1 | 1.08% | 1.25% | 1.42% | Q3 2022 | Q3 2023 | 2 |
| BIIB | BIOGEN INC | 2 | 2 | 1.08% | 1.10% | 1.12% | Q4 2022 | Q1 2023 | 2 |
| MASS | 908 DEVICES INC | 2 | 2 | 0.97% | 1.05% | 1.13% | Q1 2022 | Q2 2022 | 2 |
| BRKS | BROOKS AUTOMATION INC NEW | 2 | 2 | 0.83% | 0.93% | 1.04% | Q3 2021 | Q4 2021 | 2 |
| XENT | INTERSECT ENT INC | 2 | 2 | 0.90% | 0.91% | 0.91% | Q4 2019 | Q1 2020 | 2 |
| SDC | SMILEDIRECTCLUB INC | 2 | 2 | 0.54% | 0.83% | 1.11% | Q3 2020 | Q4 2020 | 2 |
| BMRN | BIOMARIN PHARMACEUTICA... | 1 | 1 | 0.56% | 0.80% | 1.04% | Q4 2020 | Q3 2022 | 2 |
| TMDX | TRANSMEDICS GROUP INC | 2 | 2 | 0.50% | 0.71% | 0.91% | Q3 2022 | Q4 2022 | 2 |
| RETA | REATA PHARMACEUTICALS INC | 2 | 2 | 0.34% | 0.64% | 0.94% | Q4 2019 | Q1 2020 | 2 |
| MOONLAKE IMMUNOTHERAPE... | 2 | 2 | 0.56% | 0.63% | 0.71% | Q2 2023 | Q3 2023 | 2 | |
| SIBN | SI-BONE INC | 2 | 2 | 0.60% | 0.63% | 0.65% | Q2 2023 | Q3 2023 | 2 |
| ONEM | 1LIFE HEALTHCARE INC | 2 | 2 | 0.41% | 0.62% | 0.84% | Q4 2020 | Q1 2021 | 2 |
| SMLR | SEMLER SCIENTIFIC INC | 2 | 2 | 0.43% | 0.61% | 0.79% | Q3 2021 | Q4 2021 | 2 |
| MRNA | MODERNA INC | 2 | 2 | 0.18% | 0.61% | 1.04% | Q1 2020 | Q2 2020 | 2 |
| NEO | NEOGENOMICS INC | 2 | 2 | 0.55% | 0.61% | 0.66% | Q2 2023 | Q3 2023 | 2 |
| IDYA | IDEAYA BIOSCIENCES INC | 2 | 2 | 0.52% | 0.59% | 0.66% | Q2 2023 | Q3 2023 | 2 |
| PACB | PACIFIC BIOSCIENCES CA... | 2 | 2 | 0.32% | 0.54% | 0.75% | Q2 2023 | Q3 2023 | 2 |
| NSTG | NANOSTRING TECHNOLOGIE... | 1 | 1 | 0.13% | 0.51% | 0.88% | Q3 2022 | Q2 2023 | 2 |
| CVRX | CVRX INC | 2 | 2 | 0.38% | 0.50% | 0.62% | Q2 2023 | Q3 2023 | 2 |
| GH | GUARDANT HEALTH INC | 1 | 1 | 0.25% | 0.47% | 0.68% | Q4 2019 | Q4 2022 | 2 |
| CRIS | CURIS INC | 2 | 2 | 0.41% | 0.46% | 0.52% | Q4 2020 | Q1 2021 | 2 |
| MRUS | MERUS N V | 2 | 2 | 0.31% | 0.44% | 0.56% | Q2 2023 | Q3 2023 | 2 |
| LYRA | LYRA THERAPEUTICS INC | 2 | 2 | 0.43% | 0.44% | 0.45% | Q2 2023 | Q3 2023 | 2 |
| ACAD | ACADIA PHARMACEUTICALS... | 2 | 2 | 0.42% | 0.43% | 0.44% | Q2 2023 | Q3 2023 | 2 |
| DISC MEDICINE INC | 2 | 2 | 0.38% | 0.42% | 0.45% | Q2 2023 | Q3 2023 | 2 | |
| BHVN | BIOHAVEN PHARMACTL HLD... | 1 | 1 | 0.31% | 0.41% | 0.52% | Q4 2019 | Q2 2020 | 2 |
| ARVN | ARVINAS INC | 2 | 2 | 0.38% | 0.40% | 0.43% | Q2 2023 | Q3 2023 | 2 |
| LBPH | LONGBOARD PHARMACEUTIC... | 2 | 2 | 0.36% | 0.40% | 0.44% | Q2 2023 | Q3 2023 | 2 |
| MRTX | MIRATI THERAPEUTICS INC | 2 | 2 | 0.37% | 0.39% | 0.42% | Q4 2021 | Q1 2022 | 2 |
| BDTX | BLACK DIAMOND THERAPEU... | 2 | 2 | 0.27% | 0.36% | 0.44% | Q2 2023 | Q3 2023 | 2 |
| MARINUS PHARMACEUTICAL... | 2 | 2 | 0.32% | 0.35% | 0.38% | Q1 2023 | Q2 2023 | 2 | |
| QDEL | QUIDEL CORP | 2 | 2 | 0.29% | 0.33% | 0.38% | Q2 2020 | Q3 2020 | 2 |
| NRIX | NURIX THERAPEUTICS INC | 2 | 2 | 0.08% | 0.32% | 0.56% | Q4 2021 | Q1 2022 | 2 |
| GRTX | GALERA THERAPEUTICS INC | 2 | 2 | 0.29% | 0.29% | 0.29% | Q1 2023 | Q2 2023 | 2 |
| ANAB | ANAPTYSBIO INC | 2 | 2 | 0.27% | 0.27% | 0.28% | Q4 2021 | Q1 2022 | 2 |
| TLMD | SOC TELEMED INC | 2 | 2 | 0.26% | 0.27% | 0.28% | Q1 2021 | Q2 2021 | 2 |
| ASLAN PHARMACEUTICALS LTD | 2 | 2 | 0.13% | 0.22% | 0.32% | Q2 2023 | Q3 2023 | 2 | |
| ALLK | ALLAKOS INC | 2 | 2 | 0.18% | 0.22% | 0.25% | Q1 2022 | Q2 2022 | 2 |
| ASLN | ASLAN PHARMACEUTICALS LTD | 2 | 2 | 0.16% | 0.21% | 0.25% | Q1 2021 | Q2 2021 | 2 |
| AMAM | AMBRX BIOPHARMA INC | 1 | 1 | 0.06% | 0.19% | 0.32% | Q2 2021 | Q3 2023 | 2 |
| PHAS | PHASEBIO PHARMACEUTICA... | 1 | 1 | 0.10% | 0.13% | 0.16% | Q4 2019 | Q4 2020 | 2 |
| RCKT | ROCKET PHARMACEUTICALS... | 2 | 2 | 0.12% | 0.13% | 0.14% | Q1 2022 | Q2 2022 | 2 |
| EIGR | EIGER BIOPHARMACEUTICA... | 2 | 2 | 0.12% | 0.12% | 0.12% | Q1 2022 | Q2 2022 | 2 |
| VYGR | VOYAGER THERAPEUTICS INC | 2 | 2 | 0.09% | 0.10% | 0.12% | Q2 2023 | Q3 2023 | 2 |
| CDTX | CIDARA THERAPEUTICS INC | 2 | 2 | 0.03% | 0.10% | 0.17% | Q1 2023 | Q2 2023 | 2 |
| SVRA | SAVARA INC | 2 | 2 | 0.08% | 0.09% | 0.11% | Q1 2023 | Q2 2023 | 2 |
| EYEG | EYEGATE PHARMACEUTICAL... | 2 | 2 | 0.06% | 0.07% | 0.09% | Q1 2021 | Q2 2021 | 2 |
| CALA | CALITHERA BIOSCIENCES INC | 2 | 2 | 0.05% | 0.05% | 0.06% | Q2 2021 | Q3 2021 | 2 |
| MINERALYS THERAPEUTICS... | 2 | 2 | 0.03% | 0.03% | 0.03% | Q1 2023 | Q2 2023 | 2 | |
| CLPT | CLEARPOINT NEURO INC | 2 | 2 | 0.02% | 0.03% | 0.04% | Q1 2020 | Q2 2020 | 2 |
| QQQ | INVESCO QQQ TR | 1 | 1 | 3.70% | 3.70% | 3.70% | Q1 2021 | Q1 2021 | 1 |
| XBI | SPDR SER TR | 1 | 1 | 2.47% | 2.47% | 2.47% | Q4 2021 | Q4 2021 | 1 |
| TNDM | TANDEM DIABETES CARE INC | 1 | 1 | 2.32% | 2.32% | 2.32% | Q4 2019 | Q4 2019 | 1 |
| MNTA | MOMENTA PHARMACEUTICAL... | 1 | 1 | 2.21% | 2.21% | 2.21% | Q1 2020 | Q1 2020 | 1 |
| MASI | MASIMO CORP | 1 | 1 | 2.19% | 2.19% | 2.19% | Q3 2020 | Q3 2020 | 1 |
| PTLA | PORTOLA PHARMACEUTICAL... | 1 | 1 | 1.90% | 1.90% | 1.90% | Q4 2019 | Q4 2019 | 1 |
| ALXN | ALEXION PHARMACEUTICAL... | 1 | 1 | 1.52% | 1.52% | 1.52% | Q3 2020 | Q3 2020 | 1 |
| SRRA | SIERRA ONCOLOGY INC | 1 | 1 | 1.42% | 1.42% | 1.42% | Q1 2022 | Q1 2022 | 1 |
| NVRO | NEVRO CORP | 1 | 1 | 1.30% | 1.30% | 1.30% | Q2 2021 | Q2 2021 | 1 |
| PTGX | PROTAGONIST THERAPEUTI... | 1 | 1 | 1.28% | 1.28% | 1.28% | Q2 2021 | Q2 2021 | 1 |
| SRPT | SAREPTA THERAPEUTICS INC | 1 | 1 | 1.22% | 1.22% | 1.22% | Q4 2022 | Q4 2022 | 1 |
| RGNX | REGENXBIO INC | 1 | 1 | 1.00% | 1.00% | 1.00% | Q4 2019 | Q4 2019 | 1 |
| ASND | ASCENDIS PHARMA A S | 1 | 1 | 0.92% | 0.92% | 0.92% | Q4 2019 | Q4 2019 | 1 |
| FOMX | FOAMIX PHARMACEUTICALS... | 1 | 1 | 0.90% | 0.90% | 0.90% | Q4 2019 | Q4 2019 | 1 |
| KIDS | ORTHOPEDIATRICS CORP | 1 | 1 | 0.81% | 0.81% | 0.81% | Q4 2019 | Q4 2019 | 1 |
| APLT | APPLIED THERAPEUTICS INC | 1 | 1 | 0.80% | 0.80% | 0.80% | Q3 2023 | Q3 2023 | 1 |
| BLFS | BIOLIFE SOLUTIONS INC | 1 | 1 | 0.78% | 0.78% | 0.78% | Q4 2019 | Q4 2019 | 1 |
| MMS | MAXIMUS INC | 1 | 1 | 0.74% | 0.74% | 0.74% | Q2 2023 | Q2 2023 | 1 |
| INSM | INSMED INC | 1 | 1 | 0.58% | 0.58% | 0.58% | Q3 2023 | Q3 2023 | 1 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 1 | 1 | 0.57% | 0.57% | 0.57% | Q1 2021 | Q1 2021 | 1 |
| CRNX | CRINETICS PHARMACEUTIC... | 1 | 1 | 0.54% | 0.54% | 0.54% | Q3 2023 | Q3 2023 | 1 |
| SOLENO THERAPEUTICS INC | 1 | 1 | 0.54% | 0.54% | 0.54% | Q3 2023 | Q3 2023 | 1 | |
| ANGO | ANGIODYNAMICS INC | 1 | 1 | 0.54% | 0.54% | 0.54% | Q4 2021 | Q4 2021 | 1 |
| MNLO | MENLO THERAPEUTICS INC | 1 | 1 | 0.50% | 0.50% | 0.50% | Q1 2020 | Q1 2020 | 1 |
| ATRC | ATRICURE INC | 1 | 1 | 0.48% | 0.48% | 0.48% | Q1 2022 | Q1 2022 | 1 |
| FTSV | FORTY SEVEN INC | 1 | 1 | 0.46% | 0.46% | 0.46% | Q4 2019 | Q4 2019 | 1 |
| MYOV | MYOVANT SCIENCES LTD | 1 | 1 | 0.44% | 0.44% | 0.44% | Q4 2019 | Q4 2019 | 1 |
| ABOS | ACUMEN PHARMACEUTICALS... | 1 | 1 | 0.38% | 0.38% | 0.38% | Q3 2023 | Q3 2023 | 1 |
| AGIO | AGIOS PHARMACEUTICALS INC | 1 | 1 | 0.37% | 0.37% | 0.37% | Q4 2022 | Q4 2022 | 1 |
| URGN | UROGEN PHARMA LTD | 1 | 1 | 0.37% | 0.37% | 0.37% | Q3 2023 | Q3 2023 | 1 |
| APLS | APELLIS PHARMACEUTICAL... | 1 | 1 | 0.36% | 0.36% | 0.36% | Q1 2023 | Q1 2023 | 1 |
| AUGX | AUGMEDIX INC | 1 | 1 | 0.36% | 0.36% | 0.36% | Q3 2023 | Q3 2023 | 1 |
| INOV | INOVALON HLDGS INC | 1 | 1 | 0.35% | 0.35% | 0.35% | Q3 2020 | Q3 2020 | 1 |
| SIGHT SCIENCES INC | 1 | 1 | 0.34% | 0.34% | 0.34% | Q4 2022 | Q4 2022 | 1 | |
| MORF | MORPHIC HLDG INC | 1 | 1 | 0.32% | 0.32% | 0.32% | Q3 2023 | Q3 2023 | 1 |
| CYTK | CYTOKINETICS INC | 1 | 1 | 0.30% | 0.30% | 0.30% | Q4 2022 | Q4 2022 | 1 |
| TANGO THERAPEUTICS INC | 1 | 1 | 0.28% | 0.28% | 0.28% | Q3 2023 | Q3 2023 | 1 | |
| STRUCTURE THERAPEUTICS... | 1 | 1 | 0.28% | 0.28% | 0.28% | Q3 2023 | Q3 2023 | 1 | |
| XAIR | BEYOND AIR INC | 1 | 1 | 0.27% | 0.27% | 0.27% | Q3 2022 | Q3 2022 | 1 |
| NTLA | INTELLIA THERAPEUTICS INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q2 2021 | Q2 2021 | 1 |
| PEPGEN INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q3 2022 | Q3 2022 | 1 | |
| XNCR | XENCOR INC | 1 | 1 | 0.25% | 0.25% | 0.25% | Q4 2019 | Q4 2019 | 1 |
| RAPID MICRO BIOSYSTEMS... | 1 | 1 | 0.24% | 0.24% | 0.24% | Q4 2021 | Q4 2021 | 1 | |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 1 | 1 | 0.23% | 0.23% | 0.23% | Q3 2020 | Q3 2020 | 1 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1 | 1 | 0.21% | 0.21% | 0.21% | Q3 2022 | Q3 2022 | 1 |
| FATE | FATE THERAPEUTICS INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q4 2020 | Q4 2020 | 1 |
| IRWD | IRONWOOD PHARMACEUTICA... | 1 | 1 | 0.18% | 0.18% | 0.18% | Q3 2023 | Q3 2023 | 1 |
| GDRX | GOODRX HLDGS INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q3 2020 | Q3 2020 | 1 |
| ETON | ETON PHARMACEUTICALS INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q3 2023 | Q3 2023 | 1 |
| AADI BIOSCIENCE INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2023 | Q1 2023 | 1 | |
| BFLY | BUTTERFLY NETWORK INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2021 | Q1 2021 | 1 |
| CUTR | CUTERA INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q3 2023 | Q3 2023 | 1 |
| GRTS | GRITSTONE BIO INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q1 2023 | Q1 2023 | 1 |
| STIM | NEURONETICS INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q3 2022 | Q3 2022 | 1 |
| MRNS | MARINUS PHARMACEUTICAL... | 1 | 1 | 0.07% | 0.07% | 0.07% | Q2 2020 | Q2 2020 | 1 |
| UBX | UNITY BIOTECHNOLOGY INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2022 | Q3 2022 | 1 |
| UNITY BIOTECHNOLOGY INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2022 | Q4 2022 | 1 | |
Download | |||||||||
The securities at the top of the list , including DEXCOM INC, ACLARIS THERAPEUTICS INC, and XENON PHARMACEUTICALS INC, are the highest-conviction holdings of Parkman Healthcare Partners LLC.
The conviction is calculated by counting the number of quarters a security has been reported by Parkman Healthcare Partners LLC. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Parkman Healthcare Partners LLC owns currently or has owned in the past.